Janus Devices for Gastrointestinal Drug Delivery by Lee, Young-Ah
Wellesley College
Wellesley College Digital Scholarship and Archive
Honors Thesis Collection
2014
Janus Devices for Gastrointestinal Drug Delivery
Young-Ah Lee
ylee6@wellesley.edu
Follow this and additional works at: https://repository.wellesley.edu/thesiscollection
This Dissertation/Thesis is brought to you for free and open access by Wellesley College Digital Scholarship and Archive. It has been accepted for
inclusion in Honors Thesis Collection by an authorized administrator of Wellesley College Digital Scholarship and Archive. For more information,
please contact ir@wellesley.edu.
Recommended Citation















Young-Ah (Lucy) Lee 
 
Advisors: Dr. Nolan T. Flynn, Wellesley College Chemistry 
Dr. Robert S. Langer & Dr. C. Giovanni Traverso, MIT Chemical Engineering 
 
 
Submitted in partial fulfillment of the requirements for  
Bachelor of Arts Degree with Honors in Chemistry  











As medication compliance presents a key challenge for patients, there is a significant 
need for enabling longer retention of drug-delivery vehicles to provide extended drug release. 
This project aims to develop a drug-delivery device with the unique capacity for extended 
gastrointestinal (GI) retention and drug release. The goal is accomplished by fabricating a novel 
Janus device with an omniphobic (repellent to everything) side and a mucosal adhesive side. 
This dual-layer system enables repulsion of the food stream by the omniphobic side and 
allows attachment to the wall of the GI tract with the mucoadhesive side. The omniphobic side 
was created using an adapted version of the Slippery Liquid-Infused Porous Surface (SLIPS) 
system. The fabrication procedure involved biomimetic morphological replication of the nano-
structures present on natural lotus leaves using soft lithography, followed by chemical surface 
modification through fluorination and lubrication. Two different approaches were used to 
achieve mucoadhesion: first, the application of mussel-inspired surface chemistry to create an 
adherent polydopamine coating and second, the use of Carbopol, a well-accepted mucoadhesive 
polymer. The morphology of the omniphobic side was visualized with scanning electron 
microscopy. Omniphobicity and mucoadhesion of each side were characterized using static 
contact angle goniometry with various liquids. The protocol for creating the desired Janus device 
was designed and carried out successfully. In vitro studies using porcine tissues demonstrated 
that the dual-sided Janus device enabled extended retention on the GI mucosal surface. Studies 
using rat models are planned to assess extended retention and drug release in vivo. With 
successful fabrication and validation, this engineered Janus device will have promising 
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1.1 The Unmet Need – Medication Compliance 
It is hard being a patient, specifically taking medications on time and at the prescribed 
doses. As Dr. C. Everett Koop said, “Drugs don’t work in patients who don’t take them.”1 
Poor compliance to treatment of chronic illnesses is a critical public health problem.2 For 
example, one study reported a 97% compliance rate at the beginning of treatment with statins, 
which are drugs used to lower cholesterol levels, but only about 50% of patients were still 
compliant after six months.3 The World Health Organization noted that compliance to long-
term therapy for chronic diseases in developed countries averages 50%; the rates of 
compliance are even lower in developing countries.2 Medication compliance poses a major 
challenge to patients, yet it is a key aspect of effective clinical care for infectious diseases. 
Thus, promoting compliance to existing therapies may be the best investment for tackling 
chronic conditions and the most efficient method of improving health of the population.1  
The oral route remains the favored route of delivering drugs to patients.4,5 A series of 
attractive advantages support this fact, including ease of administration, flexibility on dosing, 
and avoidance of pain and discomfort usually associated with injections.4,5 Hence, much 
attention is concentrated on oral medication compliance. One approach to promote 
medication compliance for oral delivery is to extend gastrointestinal (GI) retention of the 
drug delivery system, thereby reducing the frequency of drug administration. Indeed, GI 
retention is targeted because the duration of oral drug release is predominantly limited by the 




Our goal is to develop a drug-delivery vehicle that has the unique capacity for extended 
GI retention. In order to achieve extended release of orally administered drugs, strong GI 
mucosal adhesion of the drug-carrying vehicle is needed. However, this goal is challenging 
to achieve because adhesion to the GI wall is significantly hindered by the constant passage 
of foodstuffs and bodily fluids. Hence, the drug delivery system should be designed to 
minimize the interaction with foodstuffs and reduce the likelihood of dislodgement. We 
hypothesized that a dual-sided device, called a Janus device, with an omniphobic (repellent 
to everything) side and a mucosal adhesive side could enable repulsion of the food stream 
and allow attachment to the wall of the GI tract, respectively. We propose a facile approach 
to develop a novel drug-delivery device that would avoid easy detachment by and 
aggregation with foodstuffs in the GI tract. 
 
1.2 Janus Devices  
Janus devices, initially named after the double-faced Roman god Janus, have different 
properties at opposite sides, comprising two or more components of different chemistries,"
 
Figure 1-1. Janus devices at various sizes and shapes for different applications. Adapted from Walther and 
Müller.8 
 
functionalities, and characteristics.8 Figure 1-1 shows several different geometries for Janus 
devices with each face possessing a different color.8 The term “Janus” was originally coined 
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by Casagrande and Veyssié in 1988 when they released the first publication about Janus 
devices; they made glass spherical particles with one hemisphere hydrophilic and the other 
one hydrophobic.9 Then, Pierre-Gilles de Gennes, 1991 Nobel Prize winner in physics, 
publicly reiterated the concept to the scientific community in his “Soft Matter” Nobel 
Laureate speech.10 Since then, especially in the past decade, Janus particles have gained 
much attention in a wide range of applications (e.g. in magnetics, plasmonics, colloidal 
chemistry, optics, and particularly, biomedicine); this is because of their capacity to have 
multiple functionalities and properties (optical activity, mechanical strength, magnetism, 
conductivity, etc.) within a single particle.11 In the case of drug delivery applications, Hwang 
et al. developed Janus particles with different biodegradable polymer compartments by using 
electrohydrodynamic cojetting processes, followed by controlled cross-linking.12 These Janus 
particles were composed of an interpenetrating polymer network of poly(ethylene oxide) and 
polyacrylamide/poly(acrylic acid) (PAAm-co-AA) in one hemisphere and a chemically 
cross-linked copolymer of dextran and PAAm-co-AA segments in the other compartment. 
These particles were expected to find use for orally administrated drugs, as different 
compartments released their cargo at different physiological pH, giving a complex release 
profile.  
Another biomedical use includes diagnostic applications, where Janus nanoparticles show 
potential use as probes. For example, inorganic heterodimer nanoparticles of FePt-Au with 
polyethylene glycol based ligands functionalized on their surfaces were tested as probes for 
magnetic resonance imaging (MRI) of tumor cell targets.13 The heterodimers of FePt-Au 
were conjugated with HmenB1 antibodies, which specifically recognized polysialic acid in 
tumor cells. In addition to MRI imaging, these hybrid nanoparticles had other innate 
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multimodal capabilities for biological detection, including catalytic growth effects and 
optical signal enhancing properties.  
Moreover, Janus nanoparticles with optical and magnetic properties can be applied for 
high potential diagnostic and therapeutic uses. For example, the spherical Janus 
nanocomposites of magnetic nanoparticles/pyrene-labeled poly-(styrene-block-allyl alcohol) 
were fabricated to image and treat cancer cells.14 These nanostructures had spatially 
separated functionalities for combined fluorescence imaging and magnetolytic therapy of 
cancer cells. Different from these previous studies, our project proposes an unprecedented 
design of a Janus device; it involves fabrication of a sheet-like Janus device that has a dual 
layer consisting of mucoadhesion and omniphobicity at opposite sides. 
 
1.3 Mucoadhesion 
Mucoadhesion refers to adhesion to the mucosa or the mucus membrane, which is the 
moist tissue that lines body cavities and organs, such as the mouth, nose, lungs, and urinary 
and digestive tract.15 To date, many studies have explored the optimum mucoadhesion 
considering the anatomical differences of the mucus membrane at different body regions.15 A 
material’s mucoadhesion may be affected by various factors, including molecular weight, 
hydrophilicity (through different functional groups like hydroxyl and carboxyl), pH, 
flexibility, cross-linking density, and charge and concentration of the active polymer.16,17,18 
Mucoadhesion can be measured and quantified by various evaluating methods, including 
tensile test, peel test, and shear experiments.15 Additionally, in vivo evaluation with 
fluorescent imaging, radioactive imaging, magnetic resonance imaging, and transit time 




 In terms of drug delivery systems, mucoadhesives have been widely incorporated in drug 
formulations. Mucoadhesives for oral drug delivery can help lengthen gastric residence time 
of the drug delivery system and also control the rate of drug release in a specific targeted 
region.16 Hence, mucoadhesives have the potential to enable prolonged drug bioavailability, 
which could help reduce the frequency of drug administration.22 Additionally, they allow for 
a closer contact with the targeted tissue to attain rapid absorption and enhanced penetration 
of the delivered drug. In one study, Ahmed et al. used gastric retention formulations (GRFs), 
made of naturally occurring carbohydrate polymers and loaded with the model drug 
riboflavin, to study various properties and effects of mucoadhesives.23 They carried out in 
vitro studies to examine swelling and dissolution characteristics and in vivo studies in fasted 
dogs as well as in healthy humans to assess gastric retention and drug release. The 
researchers found that when the GRFs were dried and immersed in gastric fluid, they swelled 
rapidly and released their drug content in a zero-order fashion for a period of 24 
hours. Through in vivo studies using fasted dogs, they observed that the rectangular-shaped 
GRFs stayed in the stomach for more than 9 hours, while the other shapes including cubes, 
short and long cylinders were retained less than 2 hours. Ahmed et al. concluded that these 
GRFs demonstrated extended gastric residence time and increased bioavailability of drug 
compared to the immediate release formulations.  
In another study, Salman et al. fabricated polymeric nanoparticle carriers with 
mucoadhesive properties to assess their adjuvant potential for oral vaccination.24 These 
nanoparticles were coated with thiamine to target specific sites within the GI tract, focusing 
on Peyer’s patches and enterocytes. The researchers studied the affinity of nanoparticles to 








coated nanoparticles demonstrated promise as a delivery strategy for oral vaccination and 
immunotherapy purposes. 
Mucoadhesive drug delivery systems have been developed in varying formulations, 
including powders, films, sprays, solid inserts, and gels.25 Particularly for oral delivery, 
different dosage forms include patches, pastes, ointments, adhesive gels, mouth washes, films, 
and most commonly, tablets.15 To achieve mucoadhesion in these systems, many natural and 
synthetic polymers have been employed, including: poly(ethylene glycol) (PEG), poly(vinyl 
alcohol) (PVA), poly(vinyl pyrrolidone) (PVP), poly(hydroxyethyl methacrylate) (PHEMA), 
and chitosan.15  
Specifically for our drug delivery system, two methods will be used to achieve 
mucoadhesion. The first approach involves applying mussel-inspired surface chemistry with 
the use of a small-molecule ligand, dopamine; Figure 1-2 shows the 
chemical structure of dopamine.26 The idea behind this chemistry was 
inspired by the composition of adhesive proteins in mussels that allows 
them to stick to virtually all types of inorganic and organic surfaces, wet or 
dry.26 These proteins are known to be rich in 3,4-dihydroxy-L-phenylalanine 
(DOPA) and lysine amino acids. To mimic the adhesion provided by mussel 
proteins, dopamine has been used as a molecular building block for polymer coatings, as 
dopamine contains both amine (-NH2) and catechol (-OH) functional groups. This 
biomimetic method is appealing for the fact that it does not require complicated chemical 
procedures. Through a simple dip-coating process in an aqueous solution of dopamine, it 
forms a thin surface-adherent polydopamine film on the substrate by self-polymerization. 
Studies have demonstrated the versatility of this method, as it has been used to form 
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Figure 1-3. Chemical 
structure of Carbopol. 
"
multifunctional polymer coatings onto a wide spectrum of inorganic and organic materials, 
including noble metals, oxides, polymers, semiconductors, and ceramics. Also, this method 
has been used in therapeutic biomedical applications, such as stem cell and tissue 
engineering.27,28 
The second approach involves using a well-accepted mucoadhesive polymer called 
Carbopol. Carbopol is an anionic polymer of acrylic acid lightly cross-linked with 
polyalkenyl ethers or divinyl glycol; Figure 1-3 shows the chemical 
structure of Carbopol.29 Carbopol comes in the form of a white powder 
that can be easily pill-pressed into tablets. This mucoadhesive polymer 
can undergo a phase change from liquid to semisolid rapidly, 
demonstrating strong mucoadhesion when wetted.  
 
1.4 Omniphobicity 
Unlike the wealth of applications utilizing mucoadhesion for the GI tract, the use of 
omniphobic (repellent to everything) surface coatings has been less explored. Specifically, 
the possible application of omniphobicity in drug delivery has not yet been reported. 
However, omniphobic materials have been studied for other applications. Some of the 
previously explored areas include non-wetting surfaces and biomedical fluid handling for 
applications in biomedical and optical devices.30 Vogel et al. worked on fabricating a 
transparent coating that repelled a wide variety of liquids and prevented staining.31 This 
coating also provided protection from mechanical damage and was capable of self-healing. In 
this example, omniphobicity was achieved by incorporating a colloidal monolayer that was 
backfilled with a silica precursor solution of tetraethylorthosilicate to build transparent, 
nanoporous surface structures. Through their study, a broad technological impact from solar 
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cell coatings to self-cleaning optical devices was envisioned. Moreover, other new potential 
applications of omniphobicity have been suggested and are being investigated, including for 
energy transition and environment-friendly manufacturing.32  
 Omniphobicity is much more difficult to obtain than hydrophobicity, for the surface has 
to repel other liquids, such as oil, as well as water. In order to understand the workings of 
omniphobicity, the behavior of hydrophobicity must first be understood. In the 1990s, the 
examination of a lotus leaf using scanning probe microscopy revealed that the ability of the 
lotus plant to repel water is a result of the tiny nano-structures on its leaf surface, called 
papillae.33 This discovery has inspired a field of biomimetic 
research aimed at studying and fabricating “superhydrophobic” 
surfaces using the so-called “Lotus effect.”34 The Lotus effect 
refers to the superhydrophobic behavior demonstrated when the 
surface is wetted by water and a solid-air-liquid interface is 
formed, shown in Figure 1-4; this three-phase interface is 
explained by the Cassie-Baxter model of surface wetting.35 The 
water droplet sits atop pockets of air trapped between the 
papillae and forms an almost perfect sphere. Thus, the contact area between the water and the 
surface has been drastically reduced, and the droplet can easily roll off the surface. However, 
superhydrophobic surfaces are unable to provide omniphobicity, as organic liquids, such as 
oil, are composed of nonpolar molecules that have much lower surface energy than the polar 
water molecules.34 Consequently, it is not energetically favorable for oil droplets to remain as 
spheres on the solid surface. 
 
Figure 1-4. Solid-air-liquid 
interface, explained by the 
Cassie-Baxter model.  
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1.4.1 Omniphobicity for Our System: SLIPS  
As described in the previous section, past studies have used the Lotus effect, in which a 
porous surface with arrays of nanoposts is created to give an air-liquid interface that would 
not be wetted by water.34 In addition to hydrophobic surfaces, researchers have developed 
surfaces that are not wetted by a broad range of liquids and are therefore named 
“omniphobic.”  
To achieve omniphobicity in our Janus device, we adapted the Slippery Liquid-Infused 
Porous Surface (SLIPS) system, described by Wong et al.30 Inspiration of the SLIPS came 
from the Nepenthes plant, a carnivorous pitcher plant that has micro-structures on its surface. 
These micro-structures can lock in a liquid layer to create a slick coating on which the prey 
will slip and fall into the plant. Similar to the plant, by applying a lubricating film of  
"
perfluorinated liquid in addition to the nanoposts, the SLIPS system managed to achieve 
omniphobicity through creating a liquid-liquid interface, shown in Figure 1-5(b). The SLIPS 
system gave a low-cost way to create a self-healing surface with durability to sustain physical 
stress and pressure.  
 
 
Figure 1-5.  
(a) Hydrophobicity 
achieved through an air-
liquid interface of Lotus 
effect versus (b) 
Omniphobicity achieved 
through a liquid-liquid 
interface with the addition 




Figure 1-7. Contact angle values with their 
corresponding surface characteristics when water 
is used to test the hydrophilicity or hydrophobicity 
of a surface. The blue droplets represent water.  
Figure 1-6. Schematic of contact angle 
goniometry measurement. Adapted from Ramé- 
Hart Instrument Co. 
1.4.2 Characterization of Omniphobicity  
Omniphobicity can be confirmed by contact angle goniometry, illustrated in Figure 1-6; 
this technique characterizes the strength of 
interaction of the liquid-solid interface. The 
instrument dispenses a small fixed volume 
droplet of the chosen liquid onto the surface 
of the substrate and then measures the angle 
made between the line tangent to the small 
liquid droplet and the surface. The contact 
angle measurement provides information on 
the relative hydrophilicity, hydrophobicity, and omniphobicity of the substrate surface. 
Figure 1-7 gives ranges of contact angle values and their corresponding surface 
characteristics when water is used to test the hydrophilicity or hydrophobicity of a 
surface.36,37 A surface that is omniphobic will 
show a non-zero contact angle when wetted 
by organic liquids, such as oil and hexane, 
along with a high contact angle when wetted 
by water. Static and dynamic contact angles 
with various polar and non-polar liquids, 
including water, acid and bases, organic 
solvents, and oil, will be measured to 




Figure 1-8 . Human GI tract, highlighting the 
esophagus. Adapted from A.D.A.M. 
1.5 Gastrointestinal (GI) Tract – Esophagus System""
The human GI tract can be subdivided into four major components: esophagus, stomach, 
small intestine, and large intestine. Our project specifically concentrates on providing drug 
delivery for the esophagus portion within the GI 
tract, highlighted in Figure 1-8. The esophagus 
has been overlooked as a site for drug delivery 
in comparison to the rest of the GI tract because 
of the great challenges associated with it.38 The 
esophageal tube is approximately 25 centimeters 
long and 2 centimeters wide and has a pH level 
of 6 to 7.39 As the first conduit for the GI tract, 
the esophagus transports rough, undigested food. This exposes the esophagus to 
heterogeneous materials passing through the narrow tube in a matter of a few seconds. The 
transit times range from 4 to 8 seconds for solids and 1 to 2 seconds for liquids in a healthy 
human body.40 Moreover, the stratified squamous mucosal surface is not ideal for systemic 
drug absorption.38 With these challenging conditions, a greater need arises for stronger and 
extended adhesion of the drug delivery device to the esophageal mucosa.  
A range of delivery approaches for targeting the esophagus have been previously 
explored. These include films, gels, adhesive liquids, chewing gums, orally retained lozenges, 
and also endoscopically delivered therapeutics.41 In the case of treatment for 
gastroesophageal reflux system, the liquid formulations adhere to the esophageal mucosa and 
provide a protective coating against refluxed gastric content.38 Success in achieving such a 
localized drug delivery has the capacity to fill a significant unmet need with the potential to 
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Figure 1-9. Schematic design of the Janus 
drug-delivery system.  
improve morbidity and mortality from esophageal diseases, including esophageal cancers, 
allergic conditions such as eosinophilic esophagitis, and even the more common reflux 
diseases that are all associated with medication non-compliance.42 Furthermore, the 
development of devices compatible with esophageal delivery would be directly applicable to 
delivery in the rest of the GI tract, thereby providing a universal platform for GI-based drug 
delivery.  
 
1.6 System Design 
Although many previous studies have already been conducted in each individual field of 
Janus particles, mucoadhesion, omniphobicity, and esophageal drug delivery, no work that 
integrates all these components has yet been reported. The novelty of this project is found in 
the unprecedented idea of engineering a drug-delivery Janus device with both omniphobic 
and adhesive sides for biomedical applications in the esophageal system.  
To achieve the goal of developing a drug-delivery vehicle that has the unique capacity for 
extended GI retention, our project will advance in three phases. First, for material synthesis, 
the system illustrated in Figure 1-9 will be 
constructed. A flat dual layer will be fabricated, 
in which one side is mucoadhesive, enabling 
adhesion to the GI mucosa, and the other side is 
omniphobic, repelling foodstuffs and bodily 
secretions traveling rapidly down the esophagus. 
A polymer loaded with the drug will be located 
between the two layers of the device; this 
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polymer will allow controllable release of the desired drug. The next phase involves 
conducting in vitro dislodgement tests with a simulated gastric model using pig esophageal 
and intestinal tissues, as the GI tract of pigs is most equivalent to that of humans.43 In the 
final phase, the efficacy of the fabricated Janus device will be assessed using porcine and 
rodent models in vivo, in which the stability and drug release of the device in the native GI 
environment will be evaluated. 
 
1.7 Criteria for the Optimal GI Compatible Polymer  
As described in the previous section, the purpose behind the schematic design of the 
proposed Janus system is to provide a facile approach to develop a novel drug-delivery 
device that would avoid easy detachment by and aggregation with foodstuffs in the GI tract. 
With that purpose in mind, it is crucial to choose a polymer that is optimal for the proposed 
system. This polymer would be used to construct the omniphobic side and be loaded with the 
drug for a controllable release. The criteria for the optimal polymer are that it must be GI 
compatible and robust, which means that it must be able to endure the acidic conditions of 
the GI tract, as well as be biocompatible and biodegradable. The polymer also must be able 
to be loaded with drug, which means that the use of heat should not be required for its 
polymer casting process. Furthermore, the optimal polymer should have hydroxyl (-OH) 
or/and carboxyl (-COOH) functional groups. Finally, the casting process should be simple 
and inexpensive." 
All of the components listed in the criteria are self-explanatory, except for the need of 
hydroxyl and carboxyl functional groups. To expand on the desirability of hydroxyl and 
carboxyl functional groups for the polymer, we must think about the fluorination step of the 
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fabrication process. The hydroxyl and carboxyl 
functional groups allow the polymer to be more 
easily fluorinated. The fluorination step is required to 
create an omniphobic surface and involves using the 
chemical heptadecafluoro-1,1,2,2-tetrahydrodecyl trichlorosilane. As shown in Figure 1-10, 
this molecule has a silane group at one of its ends. Consequently, through silane chemistry, 
the fluorinated substrate can undergo a condensation reaction, drawn out in Figure 1-11. 
Thus, hydroxyl or carboxyl groups are desirable for the substrate to enable silane 
modification.44 In the process of drafting the protocol to fabricate our proposed Janus device, 
different types of polymers will be considered and compared for different characteristics in 
order to choose the polymer that is optimal for our system.  
 
2. MATERIALS AND METHODS 
 
2.1 Materials 
Nanopure water was used for all aqueous sample preparations and experiments (Millipore 
Milli-Q Reference Ultrapure Water Purification System, 18.2 MΩ·cm). Acetone (AR, ACS 
grade) was purchased"from Macron Fine Chemicals (Center Valley, PA). Dichloromethane 
(HPLC grade, ≥ 99.8%) was obtained from EMD Chemicals (Gibstown, NJ).  
Figure 1-11: Schematic 
diagram depicting how 
silane modification works 
with hydroxyl groups on 
the substrate surface. 
"





For creating polydimethylsiloxane (PDMS) molds, Sylgard 184 Silicone Elastomer Kit 
was used with the base and the curing agent purchased from Dow Corning (Midland, MI). 
Fresh lotus leaves were acquired from a local company called Wonderful Water Lilies 
(Sarasota, FL), privately owned by Marilyn Eigsti. 
Poly(lactide-co-glycolide) (PLGA) (85:15, 2.22 dL/g, ester end) was purchased from 
Hangzhou Hysen Pharma Co., Ltd. (Hangzhou, China). Cellulose acetate (MW~30,000) was 
purchased from Sigma-Aldrich (St. Louis, MO). For functionalizing surfaces for 
omniphobicity, heptadecafluoro-1,1,2,2-tetrahydrodecyl trichlorosilane was purchased from 
Gelest, Inc. (Morrisville, PA), and 100% Fluorinert FC-70 Fluid was purchased from 
Hampton Research (Aliso Viejo, CA). For adhesive surfaces, Carbopol 934 was purchased 
from Lubrizol (Wickliffe, OH) and dopamine hydrochloride was purchased from Sigma-
Aldrich. Tris buffer (10 mM Tris, pH 8.5) was prepared by mixing Trizma Base, purchased 
from Sigma-Aldrich, with nanopure water. The reducing agent, sodium cyanoborohydride 
(reagent grade, 95%), was obtained from Sigma-Aldrich. All chemicals were used as 
received unless otherwise specified. 
For in vitro studies, pig tissues, including small intestine and esophagus, were procured 
from a local slaughterhouse in Massachusetts. All tissues were collected within 2 hours of the 
animal being sacrificed and kept at 4 ºC for as long as 7 days. All animal tissue work was 
approved by MIT’s Institutional Animal Care and Use Committee (IACUC), the Committee 











Figure 2-1. Steps involved in creating the SLIPS system. Adapted from Wong et al.30 
 
As described in section 1.4.1 and shown in Figure 2-1, the omniphobic surface was 
fabricated adapting a modified version of the SLIPS system by Wong et al.30 For surface 
roughening, a polymer surface with an array of nanoposts was created using a cured PDMS 
mold. Then, this epoxy-replicated nanoarray, which is now superhydrophobic, was 
chemically functionalized through fluorination and lubrication, making the surface 
omniphobic.  
2.2.1 Surface Roughening 
As illustrated in Figure 2-2, the technique of soft 
lithography was used for surface roughening. In order to 
create a polymer surface with nanoposts, a negative replica 
of a PDMS mold was needed. The natural lotus leaf was cut 
into a small piece, rinsed with nanopure water, and dried 
with nitrogen gas. Then, the leaf was glued down to a plate 
with the upper leaf side facing out for an imprinting 
procedure. PDMS solution was made with 10:1 ratio of 
Sylgard 184 Silicone Elastomer base and curing agent. 
Figure 2-2: Schematic illustration 
of the procedure for nanocasting 
PDMS negative replica and then 
nanocasting polymer positive 
replica from the cured PDMS mold. 
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Then, the PDMS solution was placed in a vacuum desiccator for approximately an hour to 
eliminate air bubbles within the solution. Afterward, the solution was poured onto the plate 
with the leaf taped down on the bottom. The mold was placed in a vacuum oven at 40 ºC 
overnight. After being taken out of the oven, the mold was placed at room temperature for an 
hour to cool down before it was peeled off from the leaf. This cured PDMS mold represented 
the lotus leaf imprint.  
Once the lotus leaf imprint was completed, either PLGA or cellulose acetate films were 
made by solvent-casting. For PLGA films, PLGA was dissolved in dichloromethane at a 
concentration of 50 mg/mL. The solution was stirred for an hour at room temperature until no 
solids could be seen. The solution was poured onto the PDMS mold, and the mold was 
placed in a 60 ºC oven until all dichloromethane was evaporated. For cellulose acetate films, 
the cellulose acetate solution of 40 mg/mL was prepared in acetone. The solution was stirred 
for an hour at room temperature until no solids could be seen. The cellulose acetate solution 
was poured onto the PDMS mold and air-dried for an hour at room temperature until all 
acetone was evaporated. Then, the polymerized film, either PLGA or cellulose acetate, was 
peeled off from the mold, creating a positive replica with the array of nanoposts.  
2.2.2 Chemical Functionalization  
The polymer positive replica with nanoposts was fluorinated by placing it in a vacuum 
desiccator overnight with 0.2 mL of heptadecafluoro-1,1,2,2-tetrahydrodecyl trichlorosilane 
in a glass vial. Then, the Fluorinert FC-70 Fluid was pipetted over the fluorinated surface to 




2.3 Fabrication of Mucoadhesive Surface 
As described in section 1.3, the procedure from the mussel-inspired surface chemistry 
was used to form an adherent polydopamine coating that binds to the substrate. First, PLGA 
was dissolved in dichloromethane at a concentration of 50 mg/mL. The solution was stirred 
for an hour at room temperature until no solids could be seen. The solution was poured onto a 
flat PDMS mold to be solvent casted. The mold was placed in a 60 ºC oven until there was a 
complete evaporation of the solvent and PLGA was fully polymerized into a thin film. Then, 
the PLGA substrate was immersed in the solution of 2 mg/mL dopamine hydrochloride with 
10 mM Tris buffer at pH 8.5. The solution was left stirring slowly overnight at room 
temperature. Subsequently, the coated polymer was gently rinsed with nanopure water to 
remove any unattached dopamine molecules.  
2.3.1 Prevention of Oxidation 
To avoid oxidation of the dopamine, which can be noted by the color change of the 
sample to dark brown, an excess amount of sodium cyanoborohydride as a reducing agent 
was mixed into the dopamine solution. Throughout the experiments, all dopamine solutions 
were deoxygenated by continuously bathing with nitrogen gas. When not in active use, all 
dopamine solutions were stored inside a vacuum desiccator, minimizing oxygen gas exposure. 
2.3.2 Alternative Approach for Mucoadhesion 
As an alternative method to the use of dopamine, a commercial mucoadhesive polymer, 
Carbopol, was used to attain mucoadhesion. Here, approximately 500 mg of Carbopol was 
pill-pressed into a tablet, at 20 MPa, using the YLJ-24T Desk-Top Powder Presser purchased 
from MTI Corporation. 
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2.4 Fabrication of Janus Devices 
The protocol to create a Janus device that is adhesive on one side and omniphobic on the 
other side was designed. Since Carbopol and cellulose acetate are both in powdered form, 
with the Carbopol powder on the bottom layer and cellulose acetate powder on the top layer, 
they were pill-pressed into a dual-layer thin tablet. A droplet of acetone was pipetted onto the 
surface of the cellulose acetate layer. Then, the tablet was quickly pressed into the PDMS 
lotus leaf mold with the wetted cellulose acetate layer facing down onto the mold. The tablet 
was pressed down for approximately 15 minutes until the acetone evaporated away. The 
tablet was detached from the PDMS mold and fluorinated and lubricated following the 
protocol stated in section 2.2.2. 
 
2.5 Surface Characterization 
The morphology of the fabricated surfaces was observed by the means of the JEOL 
5600LV Scanning Electron Microscope (SEM) located in the facilities at MIT Whitehead 
Institute, Cambridge, MA. Before visualization under SEM, all samples were sputter-coated 
with carbon using the Hummer 6.2 Sputter Coating System. Samples were cut to be under 
~0.5 cm2 in area and fixed to the aluminum stubs by double-sided adhesive carbon 
conductive tape.  
Fabricated surfaces were characterized for the degree of adhesiveness, hydrophobicity, 
and omniphobicity by taking the static contact angle measurements by the means of the 
Krüss Drop Shape Analyzer DSA100 with the software Drop Shape Analyzer (Matthews, 
NC). Contact angles of various liquid (water, organic solvents, and oil) droplets over the 
sample surface, fixed to lay flat on a horizontal plane, were measured at room temperature. A 
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fixed volume of ~250 µL droplet of the chosen liquid was dispensed onto the substrate, and 
then the contact angle made between the line tangent to the liquid 
droplet and the substrate surface was measured. The macroscopic 
droplet profile was photographed by a camera installed within the 
instrument. A sample image is shown in Figure 2-3. For each 
surface, five contact angle measurements were taken. The average 
and the standard deviation values for each surface were calculated 
and reported.  
 
2.6 In Vitro Studies Apparatus 
          
Figure 2-4. Apparatus for in vitro studies using porcine tissues. 
Macroscopic in vitro evaluation was carried out by using a self-built apparatus shown in 
Figure 2-4. Small intestinal tissue from a porcine model was cut into the length of 30 cm and 
sliced opened to line the angled slide of the apparatus. A Janus device (omniphobic and 
adhesive) and a non-Janus device (adhesive on both side) were placed at the same distance of 
22 cm from the bottom of the slide. In order to simulate the aggregation with the foodstuffs 
expected when the device is attached to the GI mucosal wall, a solid object of same mass was 
Figure 2-3: An example of 
real-time macroscopic 
droplet profile image for 
contact angle measurement. 
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purportedly placed on top of each sample. The weight also served to speed up dislodgement 
and to demonstrate adhesion or omniphobicity on the side facing up. A Masterflex L/S 
Variable-Speed Drive peristaltic pump, purchased from Cole-Parmer, was set up with some 
tygon tubing. The pump operated at the constant speed of 85 rpm and flowed water over the 
tissue. The times of dislodgment were documented and compared for the two different 
devices. Video was recorded by a hand-held digital camera and sequential photographs from 
the video recordings were collected. 
 
3. RESULTS AND DISCUSSION 
 
3.1 Creating Epoxy-replicated Nanoarray  
As described in section 1.4.1, the SLIPS system 
requires an epoxy-replicated array of nanoposts 
before fluorinating the surface and applying the 
lubricating film. The original procedure described by 
Wong et al. involved carrying out lithography using a 
silicon wafer, but we aimed to develop a more low-cost and facile method. We avoided 
purchasing a silicon wafer and instead used soft lithography with a fresh lotus leaf template 
to create a negative replica of PDMS mold with nanowells, shown in Figure 3-1. Multiple 
attempts with different order of steps and varying degrees of temperature, curing time, and 
PDMS solution ratio of base and curing agent were tried until a feasible protocol (outlined in 
section 2.2.1) successfully produced a stable PDMS mold that could morphologically 
replicate the nano-structures on the lotus leaf.  
Figure 3-1. PDMS molds with nanowells 
made from a lotus leaf template. 
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3.1.1 Verification of Negative and Positive Replicas  
Through soft lithography, negative and positive replicas were made using a lotus leaf 
template. Since the nano-structures on the lotus leaf were too small to be directly visualized, 
SEM served as a useful tool to monitor and verify the morphological replication of the 
structures. Also, contact angle measurements, where the mean values and standard deviations 
were reported along with the representative droplet profiles, were used to examine the 
changed surface characteristics. The surfaces were characterized by comparing their 
measured contact angles with those previously reported in literature, organized into ranges in 
Figure 1-7.36,37 
"
Figure 3-2. (a) SEM image of the nanowells on the negative PDMS replica. (b) Contact angle measurement of 
the negative PDMS replica compared to (c) contact angle measurement of a control PDMS. The mean values 
and standard deviations of the contact angles are reported (n = 5). 
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The negative replica, which is the PDMS mold made from the lotus leaf imprinting 
process, was expected to demonstrate nanowells. The SEM image in Figure 3-2(a) confirmed 
that the nanowells were successfully created on the PDMS mold surface. Since the surface 
was roughened by the nanowells and thus made more hydrophobic, compared to a regular 





innate hydrophobic nature of the PDMS material was verified; the unmodified control PDMS 
surface showed a contact angle of 84 ± 1º, seen in Figure 3-2(c). For the PDMS mold with 
the nanowells, we observed the expected increase in the contact angle to 114 ± 3º, seen in 
Figure 3-2(b); the contact angle increased by 30º. The literature reported contact angle values 
of ~100º for the control PDMS and ~124º for the PDMS surface with nanowells, which gave 
an increase of 24º.45 The deviation of our contact angles from the literature values was 
hypothesized to be attributed to the different type of silicone elastomer and different molding 
method used in the literature study.45 However, with a similar increase in the contact angles 
between the control and the modified PDMS, we could conclude that our experimental values 
for the negative replica showed a comparable behavior to the literature values.  
"
Figure 3-3. SEM images at (a) high magnification of a single nanopost on the positive PLGA film replica and 
(b) low magnification of the nanoposts on the positive PLGA film replica. (c) Contact angle measurement of the 
positive PLGA replica compared to (d) contact angle measurement of a control PLGA. The mean values and 
standard deviations of the contact angles are reported (n = 5). 
 
 The positive PLGA film replica prepared from the negative replica of the lotus leaf 
PDMS mold was expected to demonstrate nanoposts. The SEM images in Figure 3-3(a,b) 





Since the surface is roughened by the nanoposts and thus made superhydrophobic (>120º 
from Figure 1-7), compared to a regular PLGA polymer, we expected to see an increase in 
the contact angle measurement.45 The innate hydrophobic nature of PLGA material was 
verified, as the unmodified control PLGA surface showed a contact angle of 75 ± 2º, seen in 
Figure 3-3(d). The control PLGA surface had an intrinsic contact angle close to the values of 
75º–84º found in the literature.46,27 For the PLGA polymer with the nanoposts, we observed a 
contact angle of 133 ± 3º, seen in Figure 3-3(c); the contact angle increased by 58º. As 
discussed in section 1.4, the effect of superhydrophobicity introduced by the Lotus effect or 
the addition of nano-structures was observed.45 The contact angle of the positive PLGA 
replica (133 ± 3º) was comparable to the contact angle of the natural lotus leaf at 147 ± 3º, 
" 
Figure 3-4. Contact angles of the positive PLGA replica (left) and the natural lotus leaf (right). The mean 
values and standard deviations of the contact angles are reported (n = 5). 
 
shown in Figure 3-4. A difference of 14º was hypothesized to be attributed to either the 
material difference between the leaf and PLGA or the loss in the nanoposts’ height during the 
casting process; this was investigated further in the following section 3.1.2. Ultimately, all 
these findings indicated that the soft lithography process successfully replicated the 






3.1.2 Magnification of the Nano-structures 
 
Figure 3-5. SEM images at: (a) high magnification of the nanowells on the negative replica surface, (b) low 
magnification of the nanoposts of the positive replica surface, (c) high magnification of the nanoposts on the 
positive replica surface, (d) low magnification of the nanoposts on the natural lotus leaf surface, and (e) high 
magnification of the nanoposts on the natural lotus leaf surface. (f) A photograph of the natural lotus leaves. 
"
The replication quality of the nano-structures on the lotus leaf was assessed by the SEM 
images, displayed in Figure 3-5. The SEM images were analyzed visually using the 
appropriate scales on the images and measuring the approximate heights of the 
nanostructures for each image. Orthogonally tilted SEM images demonstrated that there was 
no loss in the height of the nanoposts created by soft lithography. The approximate height of 
10 µm was maintained throughout the molding process, as observed: the initial height of 10 
µm on the surface of the natural lotus leaf in Figure 3-5(e), the depth of 10 µm of the 
nanowells on the negative replica in Figure 3-5(a), and the height of 10 µm of the replicated 
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nanoposts on the positive replica in Figure 3-5(c). Magnification SEM images confirmed that 
the nano-structures were transferred without damages or irregularities throughout the 
molding process. Therefore, it was concluded that the replication of these nano-structure was 
at a high quality. 
 
3.2 Omniphobic Side 
 
Figure 3-6. Contact angle measurements of: (a) cellulose acetate without nanoposts, (b) hydrophobic surface - 
cellulose acetate with nanoposts, (c) omniphobic surface - cellulose acetate with nanoposts via SLIPS system, 
and (d) natural lotus leaf, using different liquids (water, hexane, and oil). The mean values and standard 
deviations of the contact angles are reported (n = 5). 
"
As described in section 1.4.2, contact angle goniometry was used to examine the changed 
surface characteristics and to confirm omniphobicity. Omniphobic surface would show a 
high contact angle with water and non-zero contact angles with organic liquids. In Figure    
3-6, the contact angle measurements, using different liquids (water, hexane, and oil), of the 
cellulose acetate surfaces modified in various ways were compared to the contact angle 
measurement of the natural lotus leaf. The mean values and standard deviations were 
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reported along with the representative droplet profiles. Row (a) represents a regular flat 
cellulose acetate surface. While the contact angle with water was 62 ± 4º, the contact angles 
with hexane and oil were both 0º. Row (b) represents a hydrophobic surface, which is the 
cellulose acetate surface with nanoposts. Even though the water droplet displayed an 
increased contact angle of 119 ± 3º due to surface roughening, the contact angles of both 
hexane and oil still remained at 0º. Row (c) represents an omniphobic surface, which is the 
cellulose acetate surface with nanoposts that has also been fluorinated and lubricated. Not 
only did the contact angle of the water droplet increase to 136 ± 5º, but also the contact 
angles of both hexane and oil were no longer 0º. The hexane droplet showed a contact angle 
of 31 ± 5º and the oil droplet showed a contact angle of 49 ± 4º. The retention of both water 
and organic liquids as visible droplets on the surface supports the fact that omniphobicity was 
achieved by surface morphological and chemical modifications.30 
" 
3.3 Mucoadhesive Side 
To obtain mucoadhesion, mussel-inspired surface chemistry (described in section 2.3) 
was initially investigated, where the substrate was dip-coated in a dopamine solution to form 
a surface-adherent coating. The contact angle analysis of the dopamine-coated polymer 
indicated a possible sign of 
mucoadhesion. As seen in Figure 
3-7, a regular PLGA film showed a 
contact angle of 75 ± 2º, compared 
to the literature value of 75º–
84º.46,27 The dopamine-coated 
PLGA showed a significantly decreased contact angle of 33 ± 4º, which was comparable to 
Figure 3-7. Contact angle measurements of PLGA (left) and 
dopamine-coated PLGA (right). The mean values and standard 




the literature value of 26º.27 The decrease in the contact angle signified that the surface was 
no longer hydrophobic.  
However, by visual observation and simple qualitative testing on the porcine small 
intestinal and esophageal tissues, the dopamine-coated polymer showed no strong 
mucoadhesion. Notably, the dopamine solutions and the 
functionalized polymers turned dark brown continuously 
during many trials, as shown in Figure 3-8. Based on some 
literature studies, we speculated that the most plausible 
reason for the lack of strong mucoadhesion was oxidation 
of the catechol groups (-OH) on the dopamine 
molecules.47,48 As explained in section 1.3, amine and 
catechol functional groups are key components for adhesion in mussel-inspired surface 
chemistry. The literature also indicated that the color change to dark brown is an apparent 
sign of oxidation.47 A notable observation during the literature studies was that no literature 
could be found, in which this mussel-inspired surface chemistry was tested on porcine tissues. "
Thus, steps were taken to prevent oxidation by using nitrogen gas to deoxygenate the 
dopamine solution and also mixing in an excess amount of a reducing agent, sodium 
cyanoborohydride, into the solution during the dip-coating process.49,50 Furthermore, 
precautionary measures, such as placing all dopamine solutions when not in active use in a 
vacuum desiccator, were taken. However, even though these measures prevented the color 
change, the functionalized polymer still did not demonstrate strong mucoadhesion when 
tested qualitatively. For continuance of this method in the future, other measures to minimize 
oxidation could be tested, such as chemically modifying the dopamine molecules into 
Figure 3-8. Oxidized dopamine 
solution and dip-coated 
polymer substrate, indicated by 
the dark brown color.  
33"
"
dopamine methacrylamide (DMA) or halogenating the dopamine molecules with chlorine. 
These were suggested in literature as potential steps to prevent oxidation of the dopamine 
molecules.48,51 Alternatively, Carbopol, a well-accepted mucoadhesive polymer that showed 
strong adhesion when wetted, was instead used for our experiments. 
 
3.4 Choosing the Optimal GI Compatible Polymer  
As described in section 1.7, the polymer that would be used to construct the omniphobic 
side and loaded with drug must be chosen carefully to carry out the purpose of our system. 
The criteria for the optimal polymer listed in section 1.7 were that it must be GI compatible, 
biocompatible, biodegradable, and durable. The polymer also must be able to be loaded with 
drug, which meant that heating should be avoided. Furthermore, the ideal polymer should 
have hydroxyl (-OH) or/and carboxyl (-COOH) functional groups. Finally, the casting 
process should be simple and inexpensive. 
"
"
       Figure 3-9: Table of candidates for the optimal GI compatible polymer with their characteristics 
"
 For the consideration of the optimal polymer, four types of polymers that are common in 
drug delivery were considered and compared in terms of different aspects, listed out in 
Figure 3-9. Amongst the four, cellulose acetate satisfied all of the key criteria. Specifically, 
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the material is inexpensive, biocompatible, biodegradable, intrinsically hydrophobic, not too 
fragile, and has hydroxyl functional groups. Additionally, it is soluble in acetone, a quickly 
evaporating solvent, and it is in a powdered form like Carbopol, which is convenient for the 
fabrication process using a pill presser. This justified our choice of cellulose acetate as the 
optimal GI compatible polymer to be used in the fabrication process of the Janus device. To 
test and demonstrate the compatibility of cellulose 
acetate with our proposed system, cellulose acetate 
was casted into a thin film and put through the 
imprinting process, described in section 2.2.1. As 
seen in Figure 3-10, the SEM image of the modified 
cellulose acetate surface showed a sign of surface 
roughening with the creation of the nano-structures, similar to those on the lotus leaf. Thus, 
the SEM analysis verified that nanoposts can be successfully replicated on cellulose acetate.  
 
3.5 Design and Fabrication of Janus Device  
Through multiple variations in polymers, solvents, casting times, 
and orders of steps, a feasible protocol was finally designed and 
verified to see that it creates a sturdy model of the Janus device, as 
shown in Figure 3-11. This protocol, outlined in section 2.4, should 
allow drug delivery with tunable loading capacity, including 
adjustable amount of drug loaded, controllable release of the desired 
drug, and protection of the drug from acidic conditions of the GI system. The drug loading 
procedure would be carried out in the step when Carbopol and cellulose acetate powdered 
forms are pill-pressed into a thin tablet. For a uniform distribution of the drug loaded onto the 
Figure  






Figure 3-10. SEM image of the nanoposts 
on the cellulose acetate polymer surface. 
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device, the chosen drug can be mixed into a homogeneous solution with cellulose acetate and 
solvent, and then that solution can be reprecipitated back into the powdered form to be pill-
pressed with the Carbopol layer. Moreover, the designed protocol also does not require 
expensive equipment, complicated chemical procedure, or long fabrication time. 
To test and demonstrate the compatibility of 
designed protocol with our proposed system, the 
finished Janus product was characterized by SEM. 
As seen in Figure 3-12, the SEM image of the 
modified cellulose acetate surface showed signs 
of surface roughening with the creation of the 
nano-structures, similar to those on the lotus leaf. 
The SEM analysis confirmed that that the nanoposts were successfully replicated from the 
lotus leaf imprint onto the cellulose acetate side of the fabricated dual layer through our 
designed protocol. Also, simple touch tests verified that the Carbopol side demonstrated 
strong mucoadhesion when wetted. Therefore, overall, the designed protocol is shown to be 
feasible, reproducible, low-cost, and efficient in its fabrication process. It also fulfills its 
purpose of delivering drug to the site of administration, as it allows for a controllable and 
extended release of the drug.  
 
3.6 In Vitro Studies 
As outlined in section 2.6, in vitro macroscopic evaluation was carried out by placing a 
Janus device (omniphobic and adhesive) and a non-Janus device (adhesive on both side) on a 
piece of porcine small intestinal tissue and pumping a stream of water over the tissue. Note 
Figure 3-12. SEM image of the nanoposts on 
the cellulose acetate side of the fabricated 
Janus device following the drafted protocol. 
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that esophageal tissue was not initially used because it was not available in time for these in 
vitro experiments. Future work will involve repeating this macroscopic evaluation using 
porcine esophageal tissues as well as other GI tissues. The time-lapse photography, shown in 
Figure 3-13, was collected from the video recording of one of the three conducted trials. All 
three trials demonstrated the same behavior and effect. "
""" """""""""
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                    t = 12.9 s          t = 13.1 s          t = 13.5 s                      t = 14.3 s 
Figure 3-13. A time-lapse photography collected from the video recording of one of the in vitro trials. The 
sample on the left represents the non-Janus device, while the sample on the right represents the Janus device. 
The red circle indicates the dislodgement of the weight from the omniphobic side of the Janus device. The 
series of the white arrows traces the dislodgement of the non-Janus device (one with the weight not detached). 
The series of the dual-colored arrows traces the retention of the Janus device (one with the weight detached). 
The mean values and standard deviations of the retention times are reported (n = 3). 
"
In the time-lapse photography shown in Figure 3-13, the distinction between the Janus 
device (right) and the non-Janus device (left) could be made by observing the dislodgement 
Non-Janus Janus 
14 ± 2 s >10 min 
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of the weight purportedly placed on top of each device. On the Janus device with the 
omniphobic side facing out, the weight would fall off the omniphobic side instantly, for the 
omniphobicity of the surface minimizes any undesirable interactions with the surface and 
foreign objects. On the other hand, on the non-Janus device with the adhesive side facing out, 
the weight would remain stuck on the adherent side. The weight was used to speed up the 
dislodgement of the devices in order to observe the effect in an accelerated time frame. It 
also represented the aggregation with the foodstuffs expected when the device is attached to 
the GI mucosal wall. The Janus device was retained on the tissue for a longer period of time 
than the non-Janus device, shown in Figure 3-13. Over the three trials, while the non-Janus 
device became dislodged after 14 ± 2 seconds, the Janus device remained stuck on the tissue 
for more than 10 minutes, at which time the measurements were stopped. We could conclude 
that this effect was seen mainly because the weight stuck on the non-Janus device created 
more interaction with the water flowing down the tissue; as the friction between the device 
and the flowing water increased, more force was exerted to bring down the device. 
The results illustrated the purpose of incorporating omniphobicity in our system design of 
the Janus device (sketched in section 1.6). This omniphobic side would prevent aggregation 
with the foodstuffs on the device when attached onto the GI mucosal wall and thus avoid 
easy detachment. Therefore, these in vitro studies confirmed our expected behavior of the 
Janus device, which demonstrated longer retention in comparison to the non-Janus device. In 
other words, these studies showed that our drug-delivery system was designed to effectively 
minimize the interaction with foodstuffs and reduce the likelihood of dislodgement, which 





A drug-delivery device with the unique capacity for extended GI retention and drug 
release was successfully developed by fabricating a novel Janus device that is low-cost, self-
healing, and durable. A flat dual layer was fabricated, in which one side is mucoadhesive, 
enabling adhesion to the GI mucosa, and the other side is omniphobic, repelling foodstuffs and 
bodily secretions traveling rapidly down the esophagus. This design with the polymer located 
between the two layers allows tunable loading capacity, including adjustable amount of drug 
loaded, controllable release of the desired drug, and protection of the drug from acidic conditions 
of the GI system.  
For the omniphobic side, the surface was first successfully modified by soft lithography 
to carry out morphological replication of the micro-structures or nanoposts on the 
superhydrophobic lotus leaves. The high quality of the replication was verified by SEM. Then, 
through chemical modification mediated by fluorination and lubrication, we were able to achieve 
omniphobicity on the surface. For the mucoadhesive side, mussel-inspired surface chemistry 
using dopamine was initially attempted, but we could not achieve the desired mucoadhesion on 
the surface. Therefore, we used an alternative mucoadhesive polymer, Carbopol, which 
demonstrated strong mucoadhesion when wetted. For future applications, different approaches 
involving chemical functionalization of various mucoadhesive ligands on platform polymers to 
attain mucoadhesion will be investigated. Omniphobicity or mucoadhesion of a side was 
characterized and verified using contact angle goniometry. The protocol for creating the desired 
Janus device was designed and carried out successfully. In vitro studies using porcine tissues 
manifested that the dual-sided nature of the Janus device allowed for extended retention on the 
GI mucosal wall.  
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Future work will include conducting Franz diffusion cell tests, in which we will show the 
effect of omniphobicity in facilitating unidirectional drug delivery. Through these diffusion tests, 
we would like to demonstrate that the drug would be released through the mucoadhesive side, 
directly to the targeted region of the mucosa, and be impermeable through the omniphobic side. 
Unidirectional drug release would give us a highly efficient drug-delivery system, in which drug 
loss and undesirable side effects are minimized. Additionally, in vivo studies will be carried out 
to assess extended retention and drug release. The stability and degradation of the fabricated 
Janus devices in the acidic environment of the GI tract will also be investigated. This would 
involve feeding fluorescently labeled devices to rodent models and monitoring the retention of 
the devices. The rats will ingest a number of devices, in which half of them will be Janus devices 
with adhesive and omniphobic sides and the other half will be non-Janus devices that are either 
completely adhesive or omniphobic. The retention extent will be compared between the devices 
by quantifying the level of fluorescence inside the rats’ GI tract. Ultimately, with successful 
fabrication and validation, this engineered Janus device will have promising biomedical 
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